Combining our research results, we can conclude that the high expression of SCRIB in CRC tissues downregulates the LATS1/2 and MOB1A/B genes, reducing the phosphorylation of YAP, increasing its translocation to the nucleus, and ultimately activating nuclear oncogenes. The gene discussed is SCRIB; the disease is colorectal carcinoma.